BSX Q3 Earnings Top, Stock Down in Premarket as Operating Margin FallsZacks Investment Research • 10/23/24
Boston Scientific (BSX) Surpasses Q3 Earnings and Revenue EstimatesZacks Investment Research • 10/23/24
Boston Scientific Shares Likely to Gain After FARAWAVE NAV ApprovalZacks Investment Research • 10/21/24
Boston Scientific Launches Next Generation of Cardiac Mapping for the FARAPULSE™ Pulsed Field Ablation SystemPRNewsWire • 10/18/24
Boston Scientific (BSX) Q3 Earnings Preview: What You Should Know Beyond the Headline EstimatesZacks Investment Research • 10/18/24
This Boston Scientific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For FridayBenzinga • 10/18/24
3 Reasons Why Growth Investors Shouldn't Overlook Boston Scientific (BSX)Zacks Investment Research • 10/15/24
Boston Scientific Corporation (BSX) Hit a 52 Week High, Can the Run Continue?Zacks Investment Research • 10/15/24
Transverse Medical Appoints Former Boston Scientific EVP and Global Chief Medical Officer, Professor Ian T. Meredith, to Board of DirectorsBusiness Wire • 10/11/24
Boston Scientific (BSX) Rises Yet Lags Behind Market: Some Facts Worth KnowingZacks Investment Research • 10/04/24
Global Expansion, Strategic Innovations Aid Boston Scientific StockZacks Investment Research • 10/02/24
Boston Scientific Announces Conference Call Discussing Third Quarter 2024 ResultsPRNewsWire • 10/02/24
Boston Scientific Receives Japanese Regulatory Approval for the FARAPULSE™ Pulsed Field Ablation SystemPRNewsWire • 09/27/24